Dissection of the molecular mechanism of action of GW5638, a novel estrogen receptor ligand, provides insights into the role of estrogen receptor in bone

Endocrinology

Volumn 138, Issue 9, 1997, Pages 3901-3911

  Willson, T M ^a   Norris, J D ^b   Wagner, B L ^b   Asplin, I ^b   Baer, P ^a   Brown, H R ^a   Jones, S A ^a   Henke, B ^a   Sauls, H ^a   Wolfe, S ^a   Morris, D C ^a   Mcdonnell, D P ^b  

^a GLAXOSMITHKLINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1,2 DIPHENYL 1 BUTENYL)CINNAMIC ACID; ANTIESTROGEN; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; RALOXIFENE; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BONE ATROPHY; CARDIOVASCULAR SYSTEM; DISSECTION; ESTROGEN BLOOD LEVEL; GENE EXPRESSION; GENE TARGETING; LIGAND BINDING; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; TRANSCRIPTION REGULATION;

EID: 0030741983     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.9.5358     Document Type: Article

References (11)

1. Evans RM 1988 The steroid and thyroid hormone receptor superfamily. Science 240:889-895
2. O'Malley BW, Tsai SY, Bagchi M, Weigel NL, Schrader WT, Tsai M-J 1991 Molecular mechanism of action of a steroid hormone receptor. Recent Prog Horm Res 47:1-26
3. Tora L, White J, Brou C, Tassel D, Webster N, Scheer E, Chambon P 1989 The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 59:477-487
4. Tasset D, Tora L, Fromental C, Scheer E, Chambon P 1990 Distinct classes of transcriptional activating domains function by different mechansims. Cell 62:1177-1187
5. McDonnell DP, Clemm DL, Herman T, Goldman ME, Pike JW1995 Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol Endocrinol 9:659-669
6. Tzukerman MT, Esty A, Santiso-Mere D, Danielian P, Parker MG, Stein RB, Pike JW, McDonnell DP 1994 Human estrogen receptor transcriptional capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol 8:21-30
7. Clark JH, Peck EJ 1979 Female sex steroids: receptors and function. In: Clark JH, Peck EJ (eds) Monographs on Endocrinology. Springer-Verlag, New York, pp 150-167
8. Chow J, Thobias JH, Colston KW, Chambers TJ 1992 Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation. J Clin Invest 89:74-78
9. Eaker ED, Chesebro JH, Sacks FM, Wenger NK, Whisnant JP, Winston M 1993 Cardiovascular disease in women. Circulation 88:1999-2009
10. Jordan VC, Murphy CS 1990 Endocrine pharmacology of antiestrogens as antitumor agents. Endocr Rev 11:578-610
11. Parker MG 1993 Action of "pure" antiestrogens in inhibiting estrogen receptor action. Breast Cancer Res Treat 26:131-137